Article
Linking Serine/Glycine Metabolism to Radiotherapy Resistance
10 Mar 2021
Abstract excerpt
The activation of de novo serine/glycine biosynthesis in a subset of tumors has been described as a major contributor to tumor pathogenesis, poor outcome, and treatment resistance. Amplifications and mutations of de novo serine/glycine biosynthesis enzymes can trigger pathway activation; however, a large group of cancers displays serine/glycine pathway overexpression induced by oncogenic drivers and unknown...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
